RLAY Relay Therapeutics Inc
Health Care > Pharmaceuticals, Biotechnology & Life Sciences > Biotechnology > Biotechnology | NASDAQ, SmallCap, BiotechHealthcare | Last Price: 10.26 | 2026-02-27 | Atrp: 6.71
Sat 21 Feb 2026 to Fri 27 Feb 2026: Score 29
| Metric | Previous | New | Change | Interpretation | |
|---|---|---|---|---|---|
| ✅ | Operating Margin TTM | -3887.34% | -899% | ▲ 76.87% | Bullish. Higher is better. Operating margin TTM decline slowing; potential stabilization. Percentage of revenue left after operating expenses |
| ✅ | Gross Profit TTM | $-259.24M | $15.36M | ▲ 105.92% | Bullish. Higher is better. Extreme increase, but margins may be improving Revenue minus cost of goods sold over the trailing twelve months |
| ✅ | Revenue TTM | $8.36M | $15.36M | ▲ 83.78% | Bullish. Higher is better. Substantial top-line expansion Total revenue over the trailing twelve months |
| ✅ | Revenue Per Share TTM | 0.049 | 0.089 | ▲ 81.63% | Bullish. Higher is better. Substantial improvement Revenue generated per outstanding share over the trailing twelve months |
| ✅ | Price Sales TTM | 180.4793 | 103.3952 | ▼ -42.71% | Bullish. Lower is better. Lower multiple; market willing to pay less per dollar of sales Stock price divided by revenue per share over the trailing twelve months |
| ✅ | Short Ratio | 11.11 | 7.99 | ▼ -28.08% | Bullish. Lower is better. Significant improvement |
| ✅ | Short Percent | 16.8% | 13.91% | ▼ -17.2% | Bullish. Lower is better. Moderate decrease; still high, potential for squeeze if positive catalysts emerge Percentage of shares sold short |
| ✅ | EBITDA | $-320.5M | $-299.18M | ▲ 6.65% | Bullish. Higher is better. Increase in earnings before interest, taxes, depreciation, and amortization; indicates stronger operational cash flow Earnings before interest, taxes, depreciation, and amortization |
| ✅ | Enterprise Value | $0.98B | $1.02B | ▲ 3.87% | Bullish. Higher is better. Increased, reflecting higher market cap and possibly debt adjustments Market capitalization plus debt minus cash |
| ❌ | Price Book MRQ | 2.544 | 2.6296 | ▲ 3.36% | Bearish. Lower is better. Further to 1; more overvalued on assets but worsened perception Stock price divided by book value per share for the most recent quarter |
| ❌ | Book Value | 3.52 | 3.261 | ▼ -7.36% | Bearish. Higher is better. Slight decrease; stock now trades further from book value Net asset value of the company per share |
| ❌ | Enterprise Value/Revenue | 117.6462 | 123.8696 | ▲ 5.29% | Bearish. Lower is better. Slight decline Enterprise value divided by revenue |
Sat 14 Feb 2026 to Sat 21 Feb 2026: Score 2
| Metric | Previous | New | Change | Interpretation | |
|---|---|---|---|---|---|
| ✅ | Price Sales TTM | 185.2506 | 180.4793 | ▼ -2.58% | Bullish. Lower is better. Lower multiple; market willing to pay less per dollar of sales Stock price divided by revenue per share over the trailing twelve months |
| ✅ | Institutional Ownership | 98.172% | 101.364% | ▲ 3.25% | Bullish. Higher is better. Slight increase; continued strong interest from big investors Percentage held by institutions like mutual funds |
Sat 07 Feb 2026 to Sat 14 Feb 2026: Score -3
| Metric | Previous | New | Change | Interpretation | |
|---|---|---|---|---|---|
| ❌ | Short Ratio | 10.46 | 11.11 | ▲ 6.21% | Bearish. Lower is better. Slight decline |
| ❌ | Short Percent | 15.65% | 16.8% | ▲ 7.35% | Bearish. Lower is better. Slight increase; still high, potential for squeeze if positive catalysts emerge Percentage of shares sold short |
| ✅ | Wall Street Target Price | 14.5455 | 14.7 | ▲ 1.06% | Bullish. Higher is better. Higher analyst expectations, pointing to increased optimism for future performance Analysts' consensus target price for the stock |
Sat 31 Jan 2026 to Sat 07 Feb 2026: Score -6
| Metric | Previous | New | Change | Interpretation | |
|---|---|---|---|---|---|
| ❌ | Enterprise Value/Revenue | 92.4413 | 117.6462 | ▲ 27.27% | Bearish. Lower is better. Significant decline Enterprise value divided by revenue |
| ❌ | Price Sales TTM | 158.9048 | 185.0432 | ▲ 16.45% | Bearish. Lower is better. Higher multiple; market willing to pay more per dollar of sales Stock price divided by revenue per share over the trailing twelve months |
| ❌ | Price Book MRQ | 2.1975 | 2.544 | ▲ 15.77% | Bearish. Lower is better. Further to 1; more overvalued on assets but worsened perception Stock price divided by book value per share for the most recent quarter |
| ✅ | Enterprise Value | $0.77B | $0.98B | ▲ 27.27% | Bullish. Higher is better. Increased, reflecting higher market cap and possibly debt adjustments Market capitalization plus debt minus cash |
Sat 24 Jan 2026 to Sat 31 Jan 2026: Score -4
| Metric | Previous | New | Change | Interpretation | |
|---|---|---|---|---|---|
| ❌ | EPS Estimate Next Year | -1.606 | -1.6377 | ▼ -1.97% | Bearish. Higher is better. Slight lowered expectations for further out Expected earnings per share next year |
| ❌ | Price Sales TTM | 154.1335 | 158.9048 | ▲ 3.1% | Bearish. Lower is better. Higher multiple; market willing to pay more per dollar of sales Stock price divided by revenue per share over the trailing twelve months |
| ❌ | Price Book MRQ | 2.1676 | 2.1975 | ▲ 1.38% | Bearish. Lower is better. Further to 1; more overvalued on assets but worsened perception Stock price divided by book value per share for the most recent quarter |
| ❌ | Enterprise Value/Revenue | 90.2631 | 92.4413 | ▲ 2.41% | Bearish. Lower is better. Slight decline Enterprise value divided by revenue |
| ❌ | Short Ratio | 10.21 | 10.46 | ▲ 2.45% | Bearish. Lower is better. Slight decline |
| ✅ | Enterprise Value | $0.75B | $0.77B | ▲ 2.41% | Bullish. Higher is better. Increased, reflecting higher market cap and possibly debt adjustments Market capitalization plus debt minus cash |
Sat 17 Jan 2026 to Sat 24 Jan 2026: Score 1
| Metric | Previous | New | Change | Interpretation | |
|---|---|---|---|---|---|
| ✅ | Enterprise Value | $0.71B | $0.75B | ▲ 6.1% | Bullish. Higher is better. Increased, reflecting higher market cap and possibly debt adjustments Market capitalization plus debt minus cash |
| ❌ | Price Sales TTM | 152.4739 | 154.1335 | ▲ 1.09% | Bearish. Lower is better. Higher multiple; market willing to pay more per dollar of sales Stock price divided by revenue per share over the trailing twelve months |
Sat 03 Jan 2026 to Sat 10 Jan 2026: Score 3
| Metric | Previous | New | Change | Interpretation | |
|---|---|---|---|---|---|
| ✅ | Price Book MRQ | 2.4128 | 2.2788 | ▼ -5.55% | Bullish. Lower is better. Closer to 1; less overvalued on assets but improved perception Stock price divided by book value per share for the most recent quarter |
| ✅ | Enterprise Value/Revenue | 108.1036 | 98.3535 | ▼ -9.02% | Bullish. Lower is better. Slight improvement Enterprise value divided by revenue |
| ✅ | Price Sales TTM | 169.6921 | 165.7506 | ▼ -2.32% | Bullish. Lower is better. Lower multiple; market willing to pay less per dollar of sales Stock price divided by revenue per share over the trailing twelve months |
| ❌ | Enterprise Value | $0.9B | $0.82B | ▼ -9.02% | Bearish. Higher is better. Decreased, reflecting lower market cap and possibly debt adjustments Market capitalization plus debt minus cash |
Sun 21 Dec 2025 to Sat 03 Jan 2026: Score 5
| Metric | Previous | New | Change | Interpretation | |
|---|---|---|---|---|---|
| ✅ | Short Percent | 16.19% | 14.19% | ▼ -12.35% | Bullish. Lower is better. Moderate decrease; still high, potential for squeeze if positive catalysts emerge Percentage of shares sold short |
| ✅ | Price Sales TTM | 174.2559 | 169.6921 | ▼ -2.62% | Bullish. Lower is better. Lower multiple; market willing to pay less per dollar of sales Stock price divided by revenue per share over the trailing twelve months |
| ✅ | Enterprise Value | $0.89B | $0.9B | ▲ 1.16% | Bullish. Higher is better. Increased, reflecting higher market cap and possibly debt adjustments Market capitalization plus debt minus cash |
| ✅ | Short Ratio | 10.21 | 9.82 | ▼ -3.82% | Bullish. Lower is better. Slight improvement |
| ❌ | Enterprise Value/Revenue | 106.8589 | 108.1036 | ▲ 1.16% | Bearish. Lower is better. Slight decline Enterprise value divided by revenue |